3-Hydroxyphencyclidine (3-HPC), a metabolite of phencyclidine (PCP), is growing attracting clinical focus due to sparse information suggesting distinct biological actions. Current research indicate that 3-HPC may possess separate impacts on the brain structure, possibly playing a role to some of the unexpected reactions associated with PCP use. Fur